| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4021561 | Journal of Cataract & Refractive Surgery | 2009 | 6 Pages |
Abstract
Alkylphosphocholines might have the potential for topical application as a single-dose agent to prevent posterior capsule opacification formation. However, further studies are needed before a clinical application can be considered.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Kirsten H. MD, FEBO, Raffael Liegl, Marcus MD, Siegfried MD, Anselm MD, FEBO,